Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-06-05 00:00:00 ET · period of report 2025-06-03 · accession 0001415889-25-015778 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-05 | 2025-06-03 | KNSA | Ragosa Mark | CFO | S - Sale+OE | $28.80 | -18.3K | 27.0K | -40% | -$527.0K |
| D | 2025-06-05 | 2025-06-03 | KNSA | Ragosa Mark | CFO | M - OptEx | $18.00 | +18.3K | 45.3K | +68% | +$329.4K |
| D | 2025-06-05 | 2025-06-03 | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | -18.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-06-03 | S | D | 18,299 | $28.80 | 27,009 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-06-03 | M | A | 18,299 | $18.00 | 45,308 | D | — | — | |
| 3 | Derivative | Share Option | 2025-06-03 | M | D | 18,299 | $0.00 | 0 | D | $18.00 · — to 2028-05-22 | 18,299 Class A Ordinary Share | (F2) The option is fully vested and exercisable. |